Ardent Health Partners, LLC

NYSE:ARDT

Medical - Care Facilities

Healthcare
$14.40 -1.54%

-$0.14 today

Market cap
$2.03B
Beta
0.84
P/E (TTM)
9.4
EPS (TTM)
$0.95
52W Low $7.71High $15.48

Volume 7.27M

Average 0.45M

ARDT Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Ardent Health Partners, LLCNYSE: ARDT

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue grows in line with its trailing trend

Q1 FY2026 revenue of $1.6B rose 7.0% year over year, in line with the +6.7% change in trailing-twelve-month revenue. Sequentially, it fell 0.2% from the prior quarter. Over 3 fiscal years it compounded at +7.2% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 9 analysts of $6.49B (+2.6%) for the fiscal year ending Dec 2026, a slowdown from the +6.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.6B-0.2% QoQ
Last fiscal yearDec 2025
$6.32B+6.0% YoY
LTMMar 2026
$6.43B+6.7% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.0%-3.4%-10.4 pp
1 year+6.0%+2.6%-3.4 pp
3-year CAGR+7.2%+3.2%-4.0 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
6.32B USD
Year-over-year change
+6.0%
4-year CAGR
+6.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How ARDT compares with its peers on the latest reported figures

  • ARDT's LTM Mar 2026 revenue of $6.43B is the highest of the 11 companies compared; the peer median is $2.32B.
  • Its year-over-year change of +6.7% is the 7th highest of 11, against a peer median of +16.4%.
  • Over three fiscal years its annual growth of +7.2% compares with a peer median of +11.5%.
ARDT Competitors Peer median
Revenue for ARDT and competitors
Company Period LTM YoY 3-year CAGR
ARDTArdent Health Partners, LLCLTM Mar 2026$6.43B +6.7%+7.2%
SEMSelect Medical Holdings CorporationLTM Mar 2026$5.52B +29.2%-4.9%
ASTHAstrana Health, Inc.LTM Mar 2026$3.53B +56.7%+40.6%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026$3.41B +4.5%+8.3%
BKDBrookdale Senior Living Inc.LTM Sep 2026$2.95B -5.4%+4.4%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$2.68B +16.8%+10.8%
MDPediatrix Medical Group, Inc.LTM Sep 2026$1.96B +1.9%-1.0%
LFSTLifeStance Health Group, Inc.LTM Jun 2026$1.58B +20.4%+18.3%
NHCNational HealthCare CorporationLTM Sep 2026$1.58B +5.6%+12.2%
ADUSAddus HomeCare CorporationLTM Jun 2026$1.48B +15.9%+14.4%
IBRXImmunityBio, Inc.LTM Sep 2026$182.57M +121.2%+678.6%
Peer median (excluding ARDT) $2.32B+16.4%+11.5%

Competitors are the stored peer set for ARDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.87B5.13B5.41B5.97B6.32B
Cost of Revenue927.33M955.17M140.84M1.03B155.7M
Gross Profit3.94B4.17B5.27B4.93B6.17B
Gross Margin81.0%81.4%97.4%82.7%97.5%
Research & Development00000
Selling, General & Admin3.13B3.37B3.62B3.88B1.19B
Operating Expenses3.51B3.96B5.04B4.53B5.84B
Depreciation & Amortization137.2M138.17M140.84M146.29M155.7M
EBITDA526.93M531.7M350M574.93M497.26M
EBITDA Margin10.8%10.4%6.5%9.6%7.9%
Operating Income436.56M217.03M229.5M405.76M325.58M
Operating Margin9.0%4.2%4.2%6.8%5.1%
Interest Income00000
Interest Expense93.83M82.05M65.43M65.58M55.2M
Other Income / Expenses(140.68M)94.45M(77.89M)(42.7M)(39.23M)
Income Before Tax295.89M311.48M151.61M363.06M286.36M
Pre-Tax Margin6.1%6.1%2.8%6.1%4.5%
Income Tax Expense51.31M46.11M22.64M63.35M56.22M
Net Income154.26M188.91M50.29M210.34M135.81M
Net Margin3.2%3.7%0.9%3.5%2.1%
EPS (Basic)1.081.320.351.590.96
EPS (Diluted)1.081.320.351.580.96
Weighted Avg Shares143.26M143.26M143.26M132.44M140.76M
Weighted Avg Shares (Diluted)143.26M143.26M143.26M132.75M141.45M

Ardent Health Partners, LLC

NYSE:ARDT

Intrinsic Alpha fair value

Locked

Current Price

$14.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.